HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 5, Pages 468
Publisher
MDPI AG
Online
2021-04-25
DOI
10.3390/biomedicines9050468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Feedback of hypoxia-inducible factor-1alpha (HIF-1alpha) transcriptional activity via redox factor-1 (Ref-1) induction by reactive oxygen species (ROS)
- (2021) Yukino Kobayashi et al. FREE RADICAL RESEARCH
- HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential
- (2021) Siyao Li et al. Cancers
- Treatment of Diabetic Kidney Disease: Current and Future
- (2021) Tomotaka Yamazaki et al. Diabetes & Metabolism Journal
- Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial
- (2021) Masaomi Nangaku et al. AMERICAN JOURNAL OF NEPHROLOGY
- ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?
- (2021) Lucia Del Vecchio et al. Journal of Clinical Medicine
- Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF–PH inhibitor for the treatment of renal anaemia
- (2020) Silvia Lentini et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice
- (2020) Shunji Nishide et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Absorption, distribution, metabolism and excretion of molidustat in healthy participants
- (2020) Silvia Lentini et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Paradigm Shift for Treatment of Anemia in Chronic Kidney Disease?
- (2020) Ernane Souza et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-Induced Pulmonary Hypertension
- (2020) Kimberly A. Smith et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- HOW I TREAT GASTRO-INTESTINAL BLEEDING IN CONGENITAL AND ACQUIRED VON WILLEBRAND DISEASE
- (2020) Eugenia Biguzzi et al. BLOOD
- How I treat cancer-associated anemia
- (2020) Jeffrey A. Gilreath et al. BLOOD
- Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia
- (2020) Tadao Akizawa et al. Clinical Journal of the American Society of Nephrology
- Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
- (2020) Tadao Akizawa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Founding papers of current nephrology: from acute kidney injury to diabetic kidney disease
- (2020) Masaomi Nangaku KIDNEY INTERNATIONAL
- Vadadustat: First Approval
- (2020) Anthony Markham DRUGS
- Daprodustat: First Approval
- (2020) Sohita Dhillon DRUGS
- Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for Pulmonary Arterial Hypertension
- (2020) David Macias et al. EUROPEAN RESPIRATORY JOURNAL
- Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway
- (2020) Yan He et al. Gastroenterologia y Hepatologia
- Hypoxia-inducible factor signaling in pulmonary hypertension
- (2020) Soni Savai Pullamsetti et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis
- (2020) Qiyan Zheng et al. PHARMACOLOGICAL RESEARCH
- Drug‐drug interaction of atazanavir on UGT1A1‐mediated glucuronidation of molidustat in human
- (2020) Dorina Mey et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Enarodustat: First Approval
- (2020) Anthony Markham DRUGS
- Recommendations by the Asian Pacific society of nephrology ( APSN ) on the appropriate use of HIF‐PH inhibitors
- (2020) Desmond Y. H. Yap et al. NEPHROLOGY
- Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
- (2019) Matti Aapro et al. Frontiers in Pharmacology
- Near-drowning: new perspectives for human hypoxic acute kidney injury
- (2019) Samuel N Heyman et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Roxadustat: First Global Approval
- (2019) Sohita Dhillon DRUGS
- Hypoxia inducible factor‐1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway
- (2019) Jie Han et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Roxadustat and Anemia of Chronic Kidney Disease
- (2019) Joshua Kaplan NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
- (2019) Nan Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molidustat for the treatment of renal anaemia in patients with non-dialysis-dependent chronic kidney disease: design and rationale of two phase III studies
- (2019) Hiroyasu Yamamoto et al. BMJ Open
- Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies
- (2019) Tadao Akizawa et al. BMJ Open
- The Evolution of Target Hemoglobin Levels in Anemia of Chronic Kidney Disease
- (2019) Jonathan Bazeley et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach
- (2019) Sumeska Thavarajah et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway
- (2019) Jiandi Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor
- (2019) Kenji Fukui et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension
- (2019) Cheng-Jun Hu et al. EUROPEAN RESPIRATORY JOURNAL
- FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
- (2019) Daniel Edmonston et al. Nature Reviews Nephrology
- Anemia of Inflammation
- (2019) Tomas Ganz NEW ENGLAND JOURNAL OF MEDICINE
- Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage
- (2019) Marie Ito et al. KIDNEY INTERNATIONAL
- Now a Nobel gas: oxygen
- (2019) Joachim Fandrey et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Renal Medullary Hypoxia: A New Therapeutic Target for Septic Acute Kidney Injury?
- (2019) Yugeesh R. Lankadeva et al. SEMINARS IN NEPHROLOGY
- A Mass Balance Study of 14 C‐Labeled JTZ‐951 (Enarodustat), a Novel Orally Available Erythropoiesis‐Stimulating Agent, in Patients With End‐Stage Renal Disease on Hemodialysis
- (2019) Sudhakar M. Pai et al. Clinical Pharmacology in Drug Development
- Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function
- (2018) Vassilios Raptis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Maximizing Cellular Adaptation to Endurance Exercise in Skeletal Muscle
- (2018) John A. Hawley et al. Cell Metabolism
- Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury
- (2018) Yunwen Yang et al. CLINICAL SCIENCE
- Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases
- (2018) Amit A. Joharapurkar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia
- (2018) Patricia Siques et al. Frontiers in Physiology
- An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)
- (2018) Kiichi Hirota FREE RADICAL BIOLOGY AND MEDICINE
- Role of HIF-1 in Cancer Progression: Novel Insights. A Review
- (2018) Aldo Pezzuto et al. CURRENT MOLECULAR MEDICINE
- Regulation of the proprotein convertases expression and activity during regenerative angiogenesis: Role of hypoxia-inducible factor (HIF)
- (2017) Jia Ma et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Regulation of hypoxia-inducible gene expression after HIF activation
- (2017) Norio Suzuki et al. EXPERIMENTAL CELL RESEARCH
- HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism
- (2017) Volker H. Haase Hemodialysis International
- Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
- (2017) Georg Fluegen et al. NATURE CELL BIOLOGY
- Physiological Effects of Chronic Hypoxia
- (2017) John B. West NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
- (2017) Tzu-Lan Yeh et al. Chemical Science
- Targeting Protein-Protein Interactions in the HIF System
- (2016) Sarah E. Wilkins et al. ChemMedChem
- Expression of Iron Regulatory Protein 1 Is Regulated not only by HIF-1 but also pCREB under Hypoxia
- (2016) Qian-Qian Luo et al. International Journal of Biological Sciences
- Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification
- (2016) Sophie Mokas et al. KIDNEY INTERNATIONAL
- Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
- (2016) Mun Chiang Chan et al. MOLECULAR ASPECTS OF MEDICINE
- The Hypoxia Response Pathways — Hats Off!
- (2016) M. Celeste Simon NEW ENGLAND JOURNAL OF MEDICINE
- HIF2α–arginase axis is essential for the development of pulmonary hypertension
- (2016) Andrew S. Cowburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
- (2015) T. Bishop et al. CIRCULATION RESEARCH
- Oral Delivery of Prolyl Hydroxylase Inhibitor
- (2015) Ellen Marks et al. INFLAMMATORY BOWEL DISEASES
- HIF2α signaling inhibits adherens junctional disruption in acute lung injury
- (2015) Haixia Gong et al. JOURNAL OF CLINICAL INVESTIGATION
- Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling
- (2015) T. Souma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Iron-Deficiency Anemia
- (2015) Clara Camaschella NEW ENGLAND JOURNAL OF MEDICINE
- Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis
- (2015) Norio Suzuki et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult
- (2015) Melanie Vogler et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
- (2015) Tomohiro Suhara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erythropoietin Gene Expression: Developmental-Stage Specificity, Cell-Type Specificity, and Hypoxia Inducibility
- (2015) Norio Suzuki TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Renal erythropoietin-producing cells in health and disease
- (2015) Tomokazu Souma et al. Frontiers in Physiology
- Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
- (2015) Mun Chiang Chan et al. PLoS One
- HIF-1 reduces ischaemia–reperfusion injury in the heart by targeting the mitochondrial permeability transition pore
- (2014) Sang-Ging Ong et al. CARDIOVASCULAR RESEARCH
- Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury
- (2014) Pinelopi P. Kapitsinou et al. JOURNAL OF CLINICAL INVESTIGATION
- Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours
- (2014) Cameron E. Snell et al. PLoS One
- Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
- (2014) Takahisa Kawakami et al. Kidney International Supplements
- Selective Small Molecule Probes for the Hypoxia Inducible Factor (HIF) Prolyl Hydroxylases
- (2013) Rasheduzzaman Chowdhury et al. ACS Chemical Biology
- Urinary oxygen tension: a clinical window on the health of the renal medulla?
- (2013) Roger G. Evans et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Hypoxia-Inducible Factor-1 Causes Renal Cyst Expansion through Calcium-Activated Chloride Secretion
- (2013) B. Buchholz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis
- (2013) S Keely et al. Mucosal Immunology
- Origin and function of myofibroblasts in kidney fibrosis
- (2013) Valerie S LeBleu et al. NATURE MEDICINE
- Erythropoietin production in neuroepithelial and neural crest cells during primitive erythropoiesis
- (2013) Norio Suzuki et al. Nature Communications
- Regulation of hypoxia-inducible factor in kidney disease
- (2012) Masaomi Nangaku et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Expression of Prolyl Hydroxylases (PHDs) Is Selectively Controlled by HIF-1 and HIF-2 Proteins in Nucleus Pulposus Cells of the Intervertebral Disc
- (2012) Nobuyuki Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)
- (2012) Tilman B. Drüeke et al. KIDNEY INTERNATIONAL
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
- (2011) Eric V. Dang et al. CELL
- Inhibition of 2-oxoglutarate dependent oxygenases
- (2011) Nathan R. Rose et al. CHEMICAL SOCIETY REVIEWS
- Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
- (2011) Ya-Min Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice
- (2011) Nariaki Asada et al. JOURNAL OF CLINICAL INVESTIGATION
- Ischemia and reperfusion—from mechanism to translation
- (2011) Holger K Eltzschig et al. NATURE MEDICINE
- Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
- (2011) Xiaoqing Pan et al. PLoS One
- Role of the hypoxia inducible factors HIF in iron metabolism
- (2010) Carole Peyssonnaux et al. CELL CYCLE
- Utilization of an In Vivo Reporter for High Throughput Identification of Branched Small Molecule Regulators of Hypoxic Adaptation
- (2010) Natalya A. Smirnova et al. CHEMISTRY & BIOLOGY
- Hearts of Hypoxia-inducible Factor Prolyl 4-Hydroxylase-2 Hypomorphic Mice Show Protection against Acute Ischemia-Reperfusion Injury
- (2010) Jaana Hyvärinen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease
- (2010) Imari Mimura et al. Nature Reviews Nephrology
- Therapeutic Manipulation of the HIF Hydroxylases
- (2009) Simon Nagel et al. ANTIOXIDANTS & REDOX SIGNALING
- Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
- (2009) A.-T. Henze et al. CANCER RESEARCH
- Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
- (2009) Yatrik M. Shah et al. Cell Metabolism
- HIF-2α, but not HIF-1α, promotes iron absorption in mice
- (2009) Maria Mastrogiannaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
- (2009) Peter Fraisl et al. NATURE REVIEWS DRUG DISCOVERY
- Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model
- (2009) W. M. Bernhardt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
- (2009) X. Xia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 3,3′-Diindolylmethane reduces levels of HIF-1α and HIF-1 activity in hypoxic cultured human cancer cells
- (2008) Jacques E. Riby et al. BIOCHEMICAL PHARMACOLOGY
- Repression via the GATA box is essential for tissue-specific erythropoietin gene expression
- (2008) N. Obara et al. BLOOD
- Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 mutation
- (2008) D. P. Gale et al. BLOOD
- A Gain-of-Function Mutation in theHIF2AGene in Familial Erythrocytosis
- (2008) Melanie J. Percy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1α-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
- (2007) Stephen L. Archer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide induction
- (2007) Alexander Weidemann et al. BIOCHEMICAL JOURNAL
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
- (2007) Andreas Robinson et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More